FDA panel recommends approval of Theratechnologies' tesamorelin

05/27/2010 | Reuters

Theratechnologies got the unanimous endorsement of an FDA panel for tesamorelin, a drug that reduces abdominal fat in HIV patients. The FDA is scheduled to issue an approval decision by July 27.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ